key: cord-0893961-eqdfe4fk
authors: Ekanem, Emmanuel; Podder, Shreya; Donthi, Nisha; Bakhshi, Hooman; Stodghill, Joshua; Khandhar, Sandeep; Mahajan, Amit; Desai, Mehul
title: Spontaneous Pneumothorax: An Emerging Complication of COVID-19 Pneumonia
date: 2021-01-29
journal: Heart Lung
DOI: 10.1016/j.hrtlng.2021.01.020
sha: 4390baf18b860b924cebefd9731797921b86f347
doc_id: 893961
cord_uid: eqdfe4fk

Spontaneous Pneumothorax in the setting of coronavirus disease 19 (COVID-19) has been rarely described and is a potentially lethal complication. We report our institutional experience. Patients with confirmed COVID-19 who were admitted at 5 hospitals within the Inova health system between February 21 and May 2020 were included in the study. We identified 1619 patients, 22 patients (1.4%) developed spontaneous pneumothorax during their hospitalization without evidence of traumatic injury.

The deceased patients were more likely to be older (median age 63) and overweight (median BMI 28.3) ( Table 1) . As it pertains to risk factors, there was a higher prevalence of hypertension, diabetes, and congestive heart failure in the deceased patients versus patients who remain alive (75%, 50% and 25% vs 43%, 21% and 0% respectively). At the time of diagnosis of pneumothorax, the deceased patients had higher levels of inflammatory markers (Ferritin, Creactive protein and Fibrinogen) and white blood cell count. The deceased patients were also more likely to have required ventilator support (62.5% vs 29%). The patients who remain alive were more likely to have received an interleukin-6 inhibitor, remdesivir or convalescent plasma as compared to the deceased patients (50%, 29%, and 29% vs 25%, 12.5% and 0% respectively).

The most comprehensive study to date evaluating common radiographic findings associated with COVID-19 reported the incidence of pneumothorax to be 1% (1 out of 99 patients) (1) (2) . A few other case reports have presented isolated cases of pneumothorax in the setting of COVID-19. To our knowledge, this is the largest and most comprehensive description of the findings associated with spontaneous pneumothorax in COVID-19. Clinicians should be attuned to the possibility of this complication as it portends a poor prognosis.

None. 

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients

Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia

Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer